DrugPatentWatch Database Preview
VERSACLOZ Drug Profile
Which patents cover Versacloz, and what generic alternatives are available?
Versacloz is a drug marketed by Tasman Pharma and is included in one NDA.
The generic ingredient in VERSACLOZ is clozapine. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clozapine profile page.
Summary for VERSACLOZ
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 92 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VERSACLOZ at DailyMed |
Pharmacology for VERSACLOZ
| Drug Class | Atypical Antipsychotic |
Medical Subject Heading (MeSH) Categories for VERSACLOZ
US Patents and Regulatory Information for VERSACLOZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tasman Pharma | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
